In 2023, experts from across the globe gathered for an enlightening webinar on Sleep Apnea Across the Lifespan in People with Down Syndrome. Read about their findings in Down Syndrome World™ magazine: https://www.globaldownsyndrome.org/sleep-apnea-across…/
Key Takeaways:
💤 OSA Prevalence: Between 45-55% of individuals with Down syndrome are at higher risk for sleep apnea, leading to fatigue, mood issues, and cognitive deficits.
🧠 Diagnosis: Early screening (at 6 months and 4 years old) is crucial, yet many still face barriers to access, like the challenge of sleep studies and CPAP adherence.
💡 New Treatment Options: Hypoglossal Nerve Stimulation (HNS) is a promising, FDA-approved option for patients who cannot tolerate CPAP, showing significant improvements in OSA symptoms and overall well-being.
We’re working hard to raise awareness, advocate for better screening, and improve treatment options for the Down syndrome community. Join the movement for better sleep and healthier futures! 💙
